Cite
HARVARD Citation
Armuzzi, A. et al. (n.d.). Anti-TNF Agents as Therapeutic Choice in Immune-Mediated Inflammatory Diseases: Focus on Adalimumab. International journal of immunopathology and pharmacology. pp. 11-32. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Armuzzi, A. et al. (n.d.). Anti-TNF Agents as Therapeutic Choice in Immune-Mediated Inflammatory Diseases: Focus on Adalimumab. International journal of immunopathology and pharmacology. pp. 11-32. [Online].